The startup specializes in droplet microfluidics technology to facilitate the detection and selection of living biological cells, including therapeutic antibody producers and rare immune cells. This approach enables life science researchers to analyze biological samples at the single-cell level with increased speed and precision, addressing the limitations of conventional manipulation techniques.